申请人:Merck & Co., Inc.
公开号:US04381302A1
公开(公告)日:1983-04-26
(6a.alpha.,10a.alpha.,11a.alpha.)-2-(2-pyridinyl)-1,3,4,6,6a,7,8,9,10,10a,1 1,11a-dodecahydro-2H-pyrazino[1,2-b]isoquinoline and derivatives or acid addition salts thereof are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressant agents and for treating sedation caused by antihypertensive therapy.
(6a.alpha.,10a.alpha.,11a.alpha.)-2-(2-吡啶基)-1,3,4,6,6a,7,8,9,10,10a,11,11a-十二氢-2H-吡嗪[1,2-b]异喹啉及其衍生物或酸盐是选择性α2-肾上腺素能受体拮抗剂,因此可用作抗抑郁剂并用于治疗抗高血压治疗引起的镇静作用。